Publications: Emanuel Schulz
home page home page|
PubMed list |
Paper inaccessible? |
2021
Schulz E, Schumann M, Schneemann M, Dony V, Fromm A, Nagel O, Schulzke JD, Bücker R (2021) Escherichia coli alpha-hemolysin HlyA induces host cell polarity changes, epithelial barrier dysfunction and cell detachment in human colon carcinoma Caco-2 cell model via PTEN-dependent dysregulation of cell junctions.
2018
Lütt A, Michel K, Krüger D, Volz MS, Nassir M, Schulz E, Poralla L, Tangermann P, Bojarski C, Höltje M, Teegen B, Stöcker W, Schemann M, Siegmund B, Prüss H (2018) High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders. Neurogastroenterol. Motil. 30(6): e13292 (IF 3.8) [PubMed] [WebPage] [PDF]
2017
Wiegand S, Zakrzewski SS, Eichner M, Schulz E, Günzel D, Pieper R, Rosenthal R, Barmeyer C, Bleich A, Dobrindt U, Schulzke JD*, Bücker R* (*shared last authorship) (2017) Zinc treatment is efficient against Escherichia coli α haemolysin-induced intestinal leakage in mice. Sci. Rep. 7: 45649 (pages 1-13) (IF 4.1) [PubMed] [WebPage] [PDF]
2014-2016
Bücker R, Schulz E, Günzel D, Bojarski C, Lee IM, John LJ, Wiegand S, Janßen T, Wieler LH, Dobrindt U, Beutin L, Ewers C, Fromm M, Siegmund B, Troeger H, Schulzke JD (2014) α-Haemolysin of Escherichia coli: a potentiator of inflammatory activity in the colon. Gut 63(12): 1893-1901 (IF 14.7) [PubMed] [WebPage] [PDF] [Supplements]
Doctoral Thesis
Schulz E (2015) Escherichia coli α-Hämolysin - ein Entzündungsmediator bei Colitis ulcerosa. MD Thesis, Charité Berlin
